Wegovy (semaglutide) is a prescription weight-loss medication that may be covered by Aetna plans, but coverage varies by plan, location, and individual medical criteria. Many plans require prior authorization, documentation of obesity or overweight with related conditions, and adherence to step therapy or dosing guidelines. This article explains how Aetna typically handles Wegovy coverage, what criteria insurers look for, and practical steps to maximize the chance of approval.
What Wegovy Is And Why Coverage Matters
Wegovy is a once-weekly injectable prescription approved by the U.S. Food and Drug Administration for chronic weight management in adults and certain adolescents when combined with a reduced-calorie diet and physical activity. Insurance coverage significantly impacts out‑of‑pocket costs, which can influence adherence and overall treatment success. For Aetna members, understanding formulary placement and required authorizations is essential to avoid unexpected bills.
How Aetna Determines Coverage For Wegovy
Aetna generally reviews Wegovy coverage through its commercial, Medicare, and Marketplace plans using formulary tiers, medical necessity criteria, and prior authorization (PA) requirements. The key factors include:
- Medical necessity: Documentation that Wegovy is appropriate for chronic weight management in adults with a body mass index (BMI) of 30 or greater, or BMI 27 or greater with at least one weight-related condition (e.g., hypertension, type 2 diabetes, dyslipidemia).
- Prior authorization: Many plans require PA to confirm eligibility, dosing, and treatment plan. PA approvals can depend on documented attempts at lifestyle modification and failure of non-prescription alternatives.
- Step therapy: Some plans may require trying non-GLP-1 medications or non-pharmacologic strategies first, unless there is a clinical reason Wegovy is preferred.
- Formulary status: Wegovy must be on the plan’s formulary or a non-formulary exception must be granted. Availability can vary by employer group and state.
- Compliance factors: Evidence of ongoing monitoring, follow-up visits, and documentation of weight loss progress may influence continued coverage.
Common Eligibility Criteria You Might Encounter
- BMI thresholds: Typically BMI ≥ 30 kg/m² or BMI ≥ 27 kg/m² with at least one weight-related comorbidity.
- Documentation: Medical history, weight data, previous attempts at diet/exercise, and counseling notes.
- Concurrent management: A plan that includes caloric restriction and physical activity alongside Wegovy.
- Safety considerations: Absence of contraindications such as personal history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
What Aetna Members Should Do To Get Coverage
Proactive steps can improve the odds of PA approval and favorable coverage decisions:
- Check the plan’s formulary: Review the member portal or contact a benefits specialist to confirm Wegovy’s status and any PA requirements for your specific plan.
- Gather medical documentation: Compile recent weight, height to calculate BMI, comorbid conditions, previous weight-loss attempts, and a clinician’s justification for Wegovy.
- Consult with the prescriber: The prescribing clinician should draft a comprehensive PA letter that outlines the medical necessity and treatment plan, including dosage and expected outcomes.
- Prepare for potential alternatives: If Wegovy is not approved, discuss alternatives (other GLP-1 receptor agonists, non-prescription options, or lifestyle programs) and the rationale for Wegovy as first-line pharmacotherapy in certain cases.
- Monitor and document progress: Regular follow-ups, weight measurements, and safety labs (as indicated) support continued coverage in many plans.
Cost And Practical Considerations If Wegovy Is Not Covered
Even with PA approval, out-of-pocket costs can be significant. If Wegovy isn’t covered or the plan requires high co-pays, consider:
- Manufacturer savings programs: Novo Nordisk offers patient support programs and savings cards for eligible patients, which can reduce co-pays.
- Alternative therapies: Other weight-management medications or generic options, combined with lifestyle interventions, may be more cost-effective depending on plan design.
- Non-drug strategies: Comprehensive programs including nutrition counseling, physical activity plans, behavioral therapy, and community weight-management resources.
What To Expect During The Prior Authorization Process
The PA process typically involves:
- Submission: The clinician submits clinical information, BMI data, and rationale for Wegovy use.
- Review: Aetna’s medical reviewers assess eligibility, past therapies, and risk-benefit considerations.
- Decision: A PA decision is communicated with rationale and any required follow-up or step therapy guidance.
Evidence And Guidelines Shaping Coverage Decisions
Coverage decisions align with federal and clinical guidelines on obesity management. Wegovy’s approval for chronic weight management relies on demonstrating meaningful weight loss and cardiovascular risk benefits in adults with obesity or overweight with comorbidities. Insurance plans like Aetna consider these indications alongside plan-specific criteria, ensuring that medical necessity and safety are central to approval decisions.
Practical Tips To Verify Coverage For Wegovy
- Call ahead: Speak with a benefits specialist to confirm PA requirements, documentation needed, and whether a formulary exception is possible.
- Ask about coverage details: Inquire about co-pays, annual deductibles, and any patient assistance programs offered by the insurer or manufacturer.
- Document everything: Keep copies of all communications, PA approvals, and clinical notes to streamline renewals.
How Aetna Members Can Differentiate Between A Wegovy-Eligible Plan And An Ineligible One
Plans differ by employer group and location. A Wegovy-eligible plan typically features:
- Clear BMI criteria documented in plan materials or member communications.
- Explicit PA guidelines with expected timelines for approvals and renewals.
- Defined out-of-pocket costs and medication tier placement.
Key Takeaways For Aetna Coverage
- Wegovy coverage is plan-specific and often requires prior authorization.
- BMI thresholds and comorbidities commonly drive eligibility for coverage.
- Thorough documentation and a well-prepared PA application improve approval chances.
- Cost management options include manufacturer programs and alternative therapies if coverage is limited.